Immusoft

A group of executives work together to solve a puzzle
Biotech

Takeda inks another biobucks pact: $900M for Immusoft's B cells

Takeda links arms with yet another regenerative medicine biotech, this time in an up to $900 million pact with Immusoft for cell therapies.
Kyle LaHucik Oct 13, 2021 8:00am
parachute jump

Gilead continues revamp with 3 more exec exits—Chutes & Ladders

Jul 19, 2019 9:30am
People shaking hands across a desk that has computer and papers on it

Immusoft names former Amgen biologics chief as CSO

Jul 17, 2019 9:00am